Skip to menu Skip to content Skip to footer
Professor Dan Siskind
Professor

Dan Siskind

Email: 
Phone: 
+61 7 3176 2860

Overview

Background

Prof Siskind trained as a psychiatrist in Australia and the United States. He graduated from medicine at the University of Queensland in 1998. After working with Doctors Without Borders in Chechnya in 2000, he became interested in psychiatry. He moved to Boston in 2002, where he did his psychiatry residency at Boston University and a Master of Public Health at Harvard University. He returned to Brisbane in June 2008 as a clinical academic psychiatrist at the Metro South Addiction and Mental Health Service. He completed his Ph.D in Feb 2014. His research interests include clozapine and treatment refractory schizophrenia, the physical health of people with severe and persistent mental illness, supported accommodation, assertive community treatment and mental health services research. He has been awarded an NHMRC Investigator Grant as an Emerging Leadership Fellow (2021-2025) and held an NHMRC Early Career Fellowship (2016-2019). He has a current CIA MRFF RCRDUN grant looking at treatments to reduce cardiometabolic morbidity among people with schizophrenia. He has over 200 peer reviewed publications, including first author in the highly ranked Lancet, World Psychiatry, Lancet Psychiatry, BJPsych, ANZJP, & Schizophrenia Bulletin. He is a named investigator on over $40 million in competitive research grants, with over $6 million as CIA.

Availability

Professor Dan Siskind is:
Available for supervision
Media expert

Fields of research

Research interests

  • Schizophrenia

  • Physical Health Comorbidity

Works

Search Professor Dan Siskind’s works on UQ eSpace

376 works between 2007 and 2025

161 - 180 of 376 works

2020

Journal Article

Placing rehabilitation at the core of assertive community treatment

Siskind, Dan, Dark, Frances, Carney, Kylie, Gore-Jones, Victoria, Kar Ray, Manaan, Steginga, Anne, Suetani, Shuichi and Kisely, Stephen (2020). Placing rehabilitation at the core of assertive community treatment. Australasian Psychiatry, 29 (1), 47-51. doi: 10.1177/1039856220928876

Placing rehabilitation at the core of assertive community treatment

2020

Journal Article

M89. PHARMACOLOGICAL INTERVENTIONS FOR SMOKING CESSATION AMONG PEOPLE WITH SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

Siskind, Dan, Wu, Brian, Wong, Tommy and Kisely, Steve (2020). M89. PHARMACOLOGICAL INTERVENTIONS FOR SMOKING CESSATION AMONG PEOPLE WITH SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS. Schizophrenia Bulletin, 46 (Supplement_1). doi: 10.1093/schbul/sbaa030.401

M89. PHARMACOLOGICAL INTERVENTIONS FOR SMOKING CESSATION AMONG PEOPLE WITH SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

2020

Journal Article

Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic

Siskind, Dan, Northwood, Korinne, Berk, Michael, Castle, David, Galletly, Cherrie and Harris, Anthony (2020). Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic. Australian and New Zealand Journal of Psychiatry, 54 (7), 4867420927465-761. doi: 10.1177/0004867420927465

Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic

2020

Journal Article

Nose-to-brain delivery of antipsychotics using nanotechnology: a review

Tan, Madeleine S. A., Parekh, Harendra S., Pandey, Preeti, Siskind, Dan J. and Falconer, James R. (2020). Nose-to-brain delivery of antipsychotics using nanotechnology: a review. Expert Opinion on Drug Delivery, 17 (6) 17425247.2020.1762563, 839-853. doi: 10.1080/17425247.2020.1762563

Nose-to-brain delivery of antipsychotics using nanotechnology: a review

2020

Journal Article

High-dose antipsychotic therapy and reflective prescribing: development of an online tool for rapid, easy calculation of antipsychotic total daily dose

Northwood, Korinne, Theodoros, Theo, Wang, Nancy and Siskind, Dan (2020). High-dose antipsychotic therapy and reflective prescribing: development of an online tool for rapid, easy calculation of antipsychotic total daily dose. Australasian Psychiatry, 28 (4), 1039856220917080-413. doi: 10.1177/1039856220917080

High-dose antipsychotic therapy and reflective prescribing: development of an online tool for rapid, easy calculation of antipsychotic total daily dose

2020

Journal Article

Occurrence, prevention, and management of the psychological effects of emerging virus outbreaks on healthcare workers: rapid review and meta-analysis

Kisely, Steve, Warren, Nicola, McMahon, Laura, Dalais, Christine, Henry, Irene and Siskind, Dan (2020). Occurrence, prevention, and management of the psychological effects of emerging virus outbreaks on healthcare workers: rapid review and meta-analysis. BMJ, 369 m1642, m1642. doi: 10.1136/bmj.m1642

Occurrence, prevention, and management of the psychological effects of emerging virus outbreaks on healthcare workers: rapid review and meta-analysis

2020

Conference Publication

Metabolic Adverse Effects of Off-Label Use of Second-Generation Antipsychotics in the Adult Population: A Systematic Review and Meta-Analysis

Bowden, Sylvie, Tran, Veronica, Asgariroozbehani, Roshanak, McIntyre, William Brett, Agarwal, Mahavir, Siskind, Dan and Hahn, Margaret (2020). Metabolic Adverse Effects of Off-Label Use of Second-Generation Antipsychotics in the Adult Population: A Systematic Review and Meta-Analysis. 75th Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), New York, NY, United States, 30 April-2 May 2020. New York, NY, United States: Elsevier .

Metabolic Adverse Effects of Off-Label Use of Second-Generation Antipsychotics in the Adult Population: A Systematic Review and Meta-Analysis

2020

Journal Article

Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX)

Siskind, Dan, Russell, A., Gamble, C., Baker, A., Cosgrove, P., Burton, L. and Kisely, S. (2020). Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX). Journal of Psychiatric Research, 124, 9-12. doi: 10.1016/j.jpsychires.2020.02.015

Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX)

2020

Journal Article

Feasibility and acceptability of a student-led lifestyle (diet and exercise) intervention within a residential rehabilitation setting for people with severe mental illness, GO HEART (Group Occupation, Health, Exercise And Rehabilitation Treatment)

Korman, Nicole, Fox, Harley, Skinner, Tina, Dodd, Cassandra, Suetani, Shuichi, Chapman, Justin, Parker, Stephen, Dark, Frances, Collins, Cheryl, Rosenbaum, Simon and Siskind, Dan (2020). Feasibility and acceptability of a student-led lifestyle (diet and exercise) intervention within a residential rehabilitation setting for people with severe mental illness, GO HEART (Group Occupation, Health, Exercise And Rehabilitation Treatment). Frontiers in Psychiatry, 11 319, 1-12. doi: 10.3389/fpsyt.2020.00319

Feasibility and acceptability of a student-led lifestyle (diet and exercise) intervention within a residential rehabilitation setting for people with severe mental illness, GO HEART (Group Occupation, Health, Exercise And Rehabilitation Treatment)

2020

Journal Article

Predictors of unplanned discharge from community-based residential mental health rehabilitation for people affected by severe and persistent mental illness

Arnautovska, Urska, McKeon, Gemma, Dark, Frances, Siskind, Dan, Harris, Meredith and Parker, Stephen (2020). Predictors of unplanned discharge from community-based residential mental health rehabilitation for people affected by severe and persistent mental illness. Journal of Mental Health, 30 (4), 1-9. doi: 10.1080/09638237.2020.1755025

Predictors of unplanned discharge from community-based residential mental health rehabilitation for people affected by severe and persistent mental illness

2020

Conference Publication

Specific Psychiatric Features Identify Anti-NMDAR Encephalitis Before Neurological Deterioration (4888)

Warren, Nicola, O’Gorman, Cullen, Swayne, Andrew, Siskind, Dan and Blum, Stefan (2020). Specific Psychiatric Features Identify Anti-NMDAR Encephalitis Before Neurological Deterioration (4888). 2020 AAN Science Highlights, Online, 14 April 2020. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.94.15_supplement.4888

Specific Psychiatric Features Identify Anti-NMDAR Encephalitis Before Neurological Deterioration (4888)

2020

Journal Article

Consensus statement on the use of clozapine during the COVID-19 pandemic

Siskind, Dan, Honer, William G., Clark, Scott, Correll, Christoph U., Hasan, Alkomiet, Howes, Oliver, Kane, John M., Kelly, Deanna L., Laitman, Robert, Lee, Jimmy, MacCabe, James H., Myles, Nick, Nielsen, Jimmi, Schulte, Peter F., Taylor, David, Verdoux, Helene, Wheeler, Amanda and Freudenreich, Oliver (2020). Consensus statement on the use of clozapine during the COVID-19 pandemic. Journal of Psychiatry and Neuroscience, 45 (3), 222-223. doi: 10.1503/jpn.200061

Consensus statement on the use of clozapine during the COVID-19 pandemic

2020

Conference Publication

Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis

Bowden, Sylvie, Tran, Veronica, Asgariroozbehani, Roshanak, McIntyre, William Brett, Agarwal, Mahavir, Siskind, Dan and Hahn, Margaret (2020). Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis. Congress of the Schizophrenia-International-Research-Society (SRIS), Florence, Italy, 4-8 April 2020. Oxford, United Kingdom: Oxford University Press.

Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis

2020

Conference Publication

12-month follow up of metabolic measures following a randomised controlled trial of treatment of Clozapine associated obesity and diabetes with Exenatide (CODEX)

Siskind, Dan, Russell, Anthony and Kisely, Steve (2020). 12-month follow up of metabolic measures following a randomised controlled trial of treatment of Clozapine associated obesity and diabetes with Exenatide (CODEX). Congress of the Schizophrenia International Research Society (SRIS), Florence, Italy, 4-8 April 2020. Oxford, United Kingdom: Oxford University Press.

12-month follow up of metabolic measures following a randomised controlled trial of treatment of Clozapine associated obesity and diabetes with Exenatide (CODEX)

2020

Journal Article

Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine

Wagner, Elias, Honer, William G., Sommer, Iris E., Koops, Sanne, Blumberger, Daniel M., Daskalakis, Zafiris J., Dlabac-De Lange, Jozarni J., Bais, Leonie, Knegtering, Henderikus, Aleman, André, Novak, Tomas, Klirova, Monika, Slotema, Christina, Brunelin, Jerome, Poulet, Emmanuel, Kujovic, Milenko, Cordes, Joachim, Wobrock, Thomas, Siskind, Dan, Falkai, Peter, Schneider-Axmann, Thomas and Hasan, Alkomiet (2020). Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine. World Journal of Biological Psychiatry, 22 (1), 1-13. doi: 10.1080/15622975.2020.1733080

Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine

2020

Journal Article

Clozapine: a fine balance

Siskind, D. and Nielsen, J. (2020). Clozapine: a fine balance. Acta Psychiatrica Scandinavica, 141 (3), 175-177. doi: 10.1111/acps.13159

Clozapine: a fine balance

2020

Journal Article

Physical health trajectories of young people commenced on clozapine

O'Donoghue, B., Mujanovic, A., Young, S., Bridson, T., Mora, L., Bismark, M., Cocks, J., Siskind, D. and McGorry, P. (2020). Physical health trajectories of young people commenced on clozapine. Irish Journal of Psychological Medicine, 38 (1), 1-7. doi: 10.1017/ipm.2020.1

Physical health trajectories of young people commenced on clozapine

2020

Journal Article

High Intensity Interval training (HIIT) for people with severe mental illness: a systematic review & meta-analysis of intervention studies– considering diverse approaches for mental and physical recovery

Korman, Nicole, Armour, Michael, Chapman, Justin, Rosenbaum, Simon, Kisely, Steve, Suetani, Shuichi, Firth, Joseph and Siskind, Dan (2020). High Intensity Interval training (HIIT) for people with severe mental illness: a systematic review & meta-analysis of intervention studies– considering diverse approaches for mental and physical recovery. Psychiatry Research, 284 112601, 1-12. doi: 10.1016/j.psychres.2019.112601

High Intensity Interval training (HIIT) for people with severe mental illness: a systematic review & meta-analysis of intervention studies– considering diverse approaches for mental and physical recovery

2020

Journal Article

Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy

Siskind, Dan, Sidhu, Ashneet, Cross, John, Chua, Yee-Tat, Myles, Nicholas, Cohen, Dan and Kisely, Steve (2020). Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy. Australian and New Zealand Journal of Psychiatry, 54 (5) 0004867419898760, 000486741989876-481. doi: 10.1177/0004867419898760

Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy

2020

Journal Article

Antipsychotic medication exposure, clozapine, and pneumonia: results from a self-controlled study

Rohde, C., Siskind, D., de Leon, J. and Nielsen, J. (2020). Antipsychotic medication exposure, clozapine, and pneumonia: results from a self-controlled study. Acta Psychiatrica Scandinavica, 142 (2) acps.13142, 78-86. doi: 10.1111/acps.13142

Antipsychotic medication exposure, clozapine, and pneumonia: results from a self-controlled study

Funding

Current funding

  • 2024 - 2028
    A hybrid-II implementation-effectiveness trial of a peer-supported self-management tool for young people in preparation for early intervention in psychosis service discharge (MY PREP-ED) (Ex USYD)
    Medical Research Futures Fund
    Open grant
  • 2023 - 2028
    Self-care of Multimorbidity in schizophrenia supported by Peer workers: a Co-designed health Information Technology (SiMPlicITy) (externally led NHMRC 2022 Targeted Call administered via Uni of Syd)
    University of Sydney
    Open grant
  • 2023 - 2027
    Using risk profiles to overcome challenges in incorporating polygenic risk scores into clinical mental health practice (QIMR administered MRFF Genomics Health Future Mission grant)
    Queensland Institute of Medical Research
    Open grant
  • 2022 - 2029
    Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2027
    Mental Health Australia General Clinical Trial Network (MAGNET) (MRFF Million Minds Mental Health Research Grant Led by Deakin University)
    Deakin University
    Open grant
  • 2021 - 2025
    Reducing the mortality gap for people with schizophrenia
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2026
    Helping people with schizophrenia living longer, healthier lives
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2019 - 2025
    What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
    Cancer Council Australia
    Open grant

Past funding

  • 2023 - 2024
    Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz)
    University of Sydney
    Open grant
  • 2022 - 2024
    A 40-year life course study of the effects of child maltreatment using linked birth cohort and administrative health data
    Metro South Health Research Support Scheme Project Grant
    Open grant
  • 2019 - 2021
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies
    NHMRC Project Grant
    Open grant
  • 2019 - 2022
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    Society for Mental Health Research Inc
    Open grant
  • 2018 - 2019
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    The Australian Diabetes Society
    Open grant
  • 2017 - 2018
    Avant Doctors in Training Research Scholarship Program 2017
    Avant Mutual Group Limited
    Open grant
  • 2017 - 2019
    A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders
    Society for Mental Health Research Inc
    Open grant
  • 2017 - 2019
    Acceptability of physical activity measures in people with psychotic disorders
    Royal Australian & New Zealand College Psychiatrists
    Open grant
  • 2016 - 2019
    Cardiometabolic Health of People with Severe and Persistent Mental Illness
    NHMRC Early Career Fellowships
    Open grant
  • 2016 - 2019
    N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial Targeting Negative Symptoms (NHMRC Project grant administed by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2015 - 2017
    Vaporising smoking-related harms in people with severe and persistent mental illness: A study of the acceptability of vaporised nicotine products for smoking cessation or long-term substitution
    Monash University
    Open grant
  • 2015 - 2017
    Quantifying the burden of perinatal depression in Australia and New Zealand
    RANZCP Pat, Toni and Peter Kinsman Research Scholarship
    Open grant
  • 2013 - 2016
    A MAP to better care: Applying the principles of advanced directives and motivational interviewing to discharge planning for psychiatric patients
    Australian Centre for Health Services Innovation
    Open grant

Supervision

Availability

Professor Dan Siskind is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Professor Dan Siskind directly for media enquiries about:

  • Cardiometabolic co-morbidity of schizophrenia
  • Treatment Refractory Schizophrenia

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au